Takahashi, Mayumi
Wu, Xiwei
Ho, Michelle
Chomchan, Pritsana
Rossi, John J.
Burnett, John C.
Zhou, Jiehua
Article History
Received: 3 June 2016
Accepted: 31 August 2016
First Online: 22 September 2016
Competing interests
: J.J.R. and J.Z. have an issued patent entitled “Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy”. USPTO, No. US 8, 222, 226 B2, July 17, 2012. J.J.R., J.Z., M.S.W., and K.V.M. have a patent pending on “Cell-specific internalizing RNA aptamers against human CCR5 and used therefore”, United States Patent, application number: 62/025, 368, filed on July 16, 2014. J.J.R., J.Z., M.T. and J.C.B. have patent disclosures entitled “CCR7 and CD2 RNA Aptamer-Functionalized-Conjugates to Target and Activate HIV Latently Infected Lymphocytes”, City of hope, filed on Jan 2016.